Literature DB >> 23908141

Interaction of polymorphisms in mitotic regulator genes with cigarette smoking and pancreatic cancer risk.

Ji-Hyun Jang1, Michelle Cotterchio, Ayelet Borgida, Geoffrey Liu, Steven Gallinger, Sean P Cleary.   

Abstract

Mitotic regulator genes have been associated with several cancers, however little is known about their possible association with pancreatic cancer. Smoking and family history are the strongest risk factors for this highly fatal disease. The main purpose of this study was to determine if polymorphisms of mitotic regulator genes are associated with pancreatic cancer and whether they modify the association between cigarette smoking and pancreatic cancer risk. A population-based case-control study was conducted in Ontario with 455 pathology-confirmed pancreatic cancer cases and 893 controls. Cigarette smoking history was collected using questionnaires and DNA obtained from blood samples. Genotypes were determined by mass-spectrometry. Odds ratio estimates were obtained using multivariate logistic regression. Interactions between genetic variant and smoking were assessed using stratified analyses and the likelihood ratio statistic (significance P < 0.05). Variants of MCPH1, FYN, APC, PRKCA, NIN, TopBP1, RIPK1, and SNW1 were not independently associated with pancreatic cancer risk. A significant interaction was observed between pack-years and MCPH1-2550-C > T (P = 0.02). Compared to never smokers, individuals with 10-27 pack-years and MCPH1-2550-CC genotype were at increased risk for pancreatic cancer (MVOR = 2.49, 95% confidence interval [95% CI]: 1.55, 4.00) as were those with >27 pack-years and MCPH1-2550-TC genotype (MVOR = 2.42, 95% CI: 1.45, 4.05). A significant interaction was observed between smoking status and TopBP1-3257-A > G (P = 0.04) using a dominant model. Current smokers with the TopBP1-3257 A allele were at increased risk for pancreatic cancer (MVOR = 2.55, 95% CI: 1.77, 3.67). MCPH1-2550-C > T and TopBP1-3257-A > G modify the association between smoking and pancreatic cancer. These findings provide insights into the potential molecular mechanisms behind smoking-associated pancreatic cancer.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  case-control studies; mitosis; pancreatic neoplasms; polymorphism, single nucleotide; smoking

Mesh:

Substances:

Year:  2013        PMID: 23908141      PMCID: PMC4533929          DOI: 10.1002/mc.22037

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  22 in total

1.  Genetic variants in carcinogen-metabolizing enzymes, cigarette smoking and pancreatic cancer risk.

Authors:  Ji-Hyun Jang; Michelle Cotterchio; Ayelet Borgida; Steven Gallinger; Sean P Cleary
Journal:  Carcinogenesis       Date:  2012-02-02       Impact factor: 4.944

2.  RIPK1 and CASP7 polymorphism as prognostic markers for survival in patients with colorectal cancer after complete resection.

Authors:  Yee Soo Chae; Jong Gwang Kim; Sang Kyun Sohn; Su Jeong Lee; Byung Woog Kang; Joon Ho Moon; Jae Yong Park; Seong Woo Jeon; Han-Ik Bae; Gyu Seog Choi; Soo-Han Jun
Journal:  J Cancer Res Clin Oncol       Date:  2010-06-22       Impact factor: 4.553

3.  Modeling and variable selection in epidemiologic analysis.

Authors:  S Greenland
Journal:  Am J Public Health       Date:  1989-03       Impact factor: 9.308

4.  BRIT1/MCPH1 is a DNA damage responsive protein that regulates the Brca1-Chk1 pathway, implicating checkpoint dysfunction in microcephaly.

Authors:  Shiaw-Yih Lin; Rekha Rai; Kaiyi Li; Zhi-Xiang Xu; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-10       Impact factor: 11.205

5.  Ontario familial colon cancer registry: methods and first-year response rates.

Authors:  M Cotterchio; G McKeown-Eyssen; H Sutherland; G Buchan; M Aronson; A M Easson; J Macey; E Holowaty; S Gallinger
Journal:  Chronic Dis Can       Date:  2000

6.  Pancreatic cancer genetic epidemiology consortium.

Authors:  Gloria M Petersen; Mariza de Andrade; Michael Goggins; Ralph H Hruban; Melissa Bondy; Jeannette F Korczak; Steven Gallinger; Henry T Lynch; Sapna Syngal; Kari G Rabe; Daniela Seminara; Alison P Klein
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-04       Impact factor: 4.254

7.  Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism.

Authors:  R Gryfe; N Di Nicola; G Lal; S Gallinger; M Redston
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

8.  Microcephalin is a DNA damage response protein involved in regulation of CHK1 and BRCA1.

Authors:  Xingzhi Xu; Juhie Lee; David F Stern
Journal:  J Biol Chem       Date:  2004-06-25       Impact factor: 5.157

9.  Both DNA topoisomerase II-binding protein 1 and BRCA1 regulate the G2-M cell cycle checkpoint.

Authors:  Kazuhiko Yamane; Junjie Chen; Timothy J Kinsella
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

10.  ASPM and microcephalin expression in epithelial ovarian cancer correlates with tumour grade and survival.

Authors:  A Brüning-Richardson; J Bond; R Alsiary; J Richardson; D A Cairns; L McCormack; R Hutson; P Burns; N Wilkinson; G D Hall; E E Morrison; S M Bell
Journal:  Br J Cancer       Date:  2011-04-19       Impact factor: 7.640

View more
  3 in total

Review 1.  Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer.

Authors:  Chiara Birtolo; Vay Liang W Go; Andrzej Ptasznik; Guido Eibl; Stephen J Pandol
Journal:  Pancreas       Date:  2016-01       Impact factor: 3.327

Review 2.  An Overview of Genetic Changes and Risk of Pancreatic Ductal Adenocarcinoma.

Authors:  Agnieszka K Sarnecka; Malgorzata Zagozda; Marek Durlik
Journal:  J Cancer       Date:  2016-10-22       Impact factor: 4.207

3.  Analyzing the genes related to nicotine addiction or schizophrenia via a pathway and network based approach.

Authors:  Ying Hu; Zhonghai Fang; Yichen Yang; Dekai Rohlsen-Neal; Feng Cheng; Ju Wang
Journal:  Sci Rep       Date:  2018-02-13       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.